Subsequent studies have shown that leukemia cell vaccines co-expressing CD80 and GM-CSF can be used for immunotherapy of Ph+ ALL (acute lymphoblastic leukemia, ALL) patients, which can strongly inhibit the progression of leukemia. The gene discussed is CSF2; the disease is leukemia.